Mary Katofiasc Selected Research

3- (2- methoxybenzylamino)- 2- phenylpiperidine

1/2018	Colorectal and cardiovascular effects of [Lys5,MeLeu9,Nle10]-NKA(4-10) in anesthetized macaques.
1/2018	NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs.
1/2018	[Lys5,MeLeu9,Nle10]-NKA(4-10) Elicits NK2 Receptor-Mediated Micturition and Defecation, and NK1 Receptor-Mediated Emesis and Hypotension, in Conscious Dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Katofiasc Research Topics

Disease

3	Hypotension (Low Blood Pressure) 01/2018 - 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Vomiting 01/2018
1	Migraine Disorders (Migraine) 08/2006
1	Pain (Aches) 08/2006

Drug/Important Bio-Agent (IBA)

3	3- (2- methoxybenzylamino)- 2- phenylpiperidineIBA 01/2018 - 01/2018
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 01/2018
1	lysyl(3)-glycyl(8)-R-lactam-leucine(9)- neurokinin A (3-10)IBA 01/2018
1	GR 159897IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 08/2006
1	6- ((2- carboxy- 4,4- difluoro- 1- pyrrolidinyl)methyl)decahydro- 3- isoquinolinecarboxylic acidIBA 08/2006
1	Blood Proteins (Serum Proteins)IBA 08/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2006

Therapy/Procedure

1	Therapeutics 01/2018